Bookmark and Share
leucine aminopeptidase [Homo sapiens] [gi:4335941] - Target BioActivity Data
BioActivity Outcomes:
Active(25)
 
 
Inactive(44)
 
 
BioAssay Types:
Confirmatory(69)
 
 
 
BioActivity Types:
IC50(69)
 
 
 
Substance Types:
Chemical(69)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 2    Data Row: 69   Total Pages: 4   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID125311608]
[CID53315822]
Average HUM17LAP IC50 0.21Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
2
[SID125311595]
[CID53384804]
Average HUM17LAP IC50 0.28Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
3
[SID104233677]
[CID24689999]
Average HUM17LAP IC50 0.29Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
4
[SID93577810]
[CID2466]
Average HUM17LAP IC50 0.31Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
5
[SID125311594]
[CID53315819]
Average HUM17LAP IC50 0.35Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
6
[SID131485166]
[CID54758532]
Average HUM17LAP IC50 0.38Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory]
View
7
[SID131485162]
[CID25922]
Average HUM17LAP IC50 0.49Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory]
View
8
[SID125311591]
[CID53315818]
Average HUM17LAP IC50 0.52Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
9
[SID131485172]
[CID53315831]
Average HUM17LAP IC50 0.53Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory]
View
10
[SID104233678]
[CID289794]
Average HUM17LAP IC50 0.99Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
11
[SID125311590]
[CID4589721]
Average HUM17LAP IC50 1.11Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
12
[SID125311588]
[CID14545018]
Average HUM17LAP IC50 1.18Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
13
[SID125311597]
[CID12814959]
Average HUM17LAP IC50 1.64Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
14
[SID125311598]
[CID23380591]
Average HUM17LAP IC50 1.82Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
15
[SID131485168]
[CID54758533]
Average HUM17LAP IC50 2.77Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory]
View
16
[SID125311593]
[CID53384800]
Average HUM17LAP IC50 4.58Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
17
[SID125311596]
[CID142752]
Average HUM17LAP IC50 8.23Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
18
[SID131485169]
[CID25164]
Average HUM17LAP IC50 8.38Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory]
View
19
[SID125311599]
[CID10171341]
Average HUM17LAP IC50 8.67Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View
20
[SID125311589]
[CID53384801]
Average HUM17LAP IC50 16.19Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory]
View